Local Management of Oligometastases in Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Riudavets Melia, M. [1 ]
Del Carpio Huerta, L. [1 ]
Barba Joaquin, A. [1 ]
Anguera Palacios, G. [1 ]
Sullivan, I. [1 ]
Callejo Perez, A. [1 ]
Farre, N. [2 ]
Torrego, A. [3 ]
Pajares, V. [3 ]
Martinez, E. [4 ]
Trujillo, J. C. [4 ]
De Quinana, C. [5 ]
Majem Tarruella, M. [1 ]
机构：
[1] Hosp La Santa Creu & St Pau, Med Oncol, Barcelona, Spain
[2] Hosp La Santa Creu & St Pau, Radiat Oncol, Barcelona, Spain
[3] Hosp La Santa Creu & St Pau, Pneumol, Barcelona, Spain
[4] Hosp La Santa Creu & St Pau, Orac Surg, Barcelona, Spain
[5] Hosp La Santa Creu & St Pau, Neurosurg, Barcelona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Non-Small Cell Lung Cancer; Oligometastases; Management;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-072
引用
收藏
页码：S2095 / S2095
页数：1
相关论文
共 50 条
  • [41] Stereotactic Body Radiation Therapy in Metastatic Non-Small Cell Lung Cancer: For Oligometastases, Oligoprogression, and Local Control
    Lara, T. R. Merino
    Helou, J.
    Poon, I.
    Sahgal, A.
    Chung, H. T.
    Chu, W.
    Soliman, H.
    Verma, S.
    Cheema, P.
    Cheng, S.
    Khanna, S.
    Erler, D.
    Zhang, L.
    Cheung, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E440 - E441
  • [42] POSTOPERATIVE OLIGOMETASTASES IN PATIENTS WITH NON-SMALL CELL LUNG CANCER - CLINICAL MANIFESTATIONS AND THE PROGNOSIS AFTER LOCAL TREATMENT
    Yano, Tokujiro
    Yoshida, Tsukihisa
    Morodomi, Yosuke
    Ito, Kensaku
    Haro, Akira
    Shikada, Yasunori
    Maruyama, Riichiroh
    Takenoyama, Mitsuhiro
    Maehara, Yoshihiko
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S844 - S844
  • [43] Management of brain metastasized non-small cell lung cancer (NSCLC) - From local treatment to new systemic therapies
    Tsakonas, G.
    De Petris, L.
    Ekman, S.
    CANCER TREATMENT REVIEWS, 2017, 54 : 122 - 131
  • [44] IMPACT OF NATIONAL LUNG CANCER AWARENESS CAMPAIGN ON LOCAL REFERRALS AND OUTCOMES IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Calvert, L. D.
    Chatterji, S.
    THORAX, 2013, 68 : A76 - A77
  • [45] The Management of Oligometastases in Non-small Cell Lung Cancer- is Stereotactic Ablative Radiotherapy now Standard of Care?
    Ratnakumaran, R.
    McDonald, F.
    CLINICAL ONCOLOGY, 2022, 34 (11) : 753 - 760
  • [46] Audit of stage III non-small cell lung cancer (NSCLC) management in the Essex Cancer Network
    Reinius, M.
    Malek, A.
    Powrie, D.
    Yung, B.
    Ingle, C.
    Islam, M. R.
    Dancey, G.
    LUNG CANCER, 2019, 127 : S8 - S8
  • [47] Palliative thoracic radiotherapy dose, non-small cell lung cancer with oligometastases and prognosis
    Ampil, Federico L.
    Caldito, Gloria
    ANNALS OF THORACIC MEDICINE, 2011, 6 (03) : 154 - 156
  • [48] The Role of Serial Liquid Biopsy in the Management of Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Sama, Srikar
    Le, Thuy
    Ullah, Asad
    Elhelf, Islam A.
    Kavuri, Sravan K.
    Karim, Nagla Abdel
    CLINICS AND PRACTICE, 2022, 12 (03) : 419 - 424
  • [49] AFATINIB IN MANAGEMENT OF NON-SMALL CELL LUNG CANCER (NSCLC): WHAT IS EVIDENCE SO FAR?
    Lin, L.
    Josephine, M.
    RESPIROLOGY, 2014, 19 : 38 - 38
  • [50] Influence of PET/CT on the clinical Management of Patients with non-small cell Lung Cancer (NSCLC)
    Goekce-Guen, D.
    Wiest, G. H.
    Meierling, S.
    Gross-Fengels, W.
    PNEUMOLOGIE, 2020, 74 : S74 - S74
12345